Serum tissue inhibitor of metalloproteinases 1 (TIMP-1) predicts organ recovery from delayed graft function after kidney transplantation from donors after cardiac death

Mamoru Kusaka, Yoko Kuroyanagi, Manabu Ichino, Hitomi Sasaki, Takahiro Maruyama, Kunihiro Hayakawa, Ryoichi Shiroki, Atsushi Sugitani, Hiroki Kurahashi, Kiyotaka Hoshinaga

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Donors after cardiac death (DCD) have recently become an important source of renal transplants to alleviate the shortage of renal grafts in kidney transplantation (KTx), although DCD kidneys often have complications associated with a delayed graft function (DGF). A microarray-based approach using renal biopsy samples obtained at 1 h after KTx from DCD identified the tissue inhibitor of metalloproteinases 1 (TIMP-1) gene as a potential predictive marker for DGF. The current study measured serum TIMP-1 in patients undergoing KTx and analyzed the time course after KTx. The average serum TIMP-1 level before KTx was 240 ± 10 ng/ml (n = 34). In patients undergoing KTx from a living donor (n = 23), the serum TIMP-1 levels showed no increase after KTx (POD1: 226 ± 12, POD2: 211 ± 12, and POD3: 195 ± 10 ng/ml), but in one case, the only patient who required post-KTx HD due to DGF, the level on POD1 was the highest among subjects (361 ng/ml). In contrast, patients undergoing KTx from DCDs (n = 11), the serum TIMP-1 levels increased rapidly after a KTx (POD1: 418 ± 32, POD2: 385 ± 42, and POD3: 278 ± 25 ng/ml). However, two patients who avoided post-KTx HD due to the immediate function of the graft did not show increased levels (<370 ng/ml) on either POD1 or POD2. The peak serum TIMP-1 values appeared to correlate to the post-KTx dialysis period. Furthermore, the increment of serum TIMP-1 on the early POD was found to be predictive of immediate or delayed function of the grafts. These data suggest that monitoring of serum TIMP-1 levels allow the prediction of graft recovery and the need for HD after a KTx from a DCD.

Original languageEnglish
Pages (from-to)723-729
Number of pages7
JournalCell Transplantation
Volume19
Issue number6-7
DOIs
Publication statusPublished - 01-11-2010

Fingerprint

Transplantation (surgical)
Delayed Graft Function
Tissue Inhibitor of Metalloproteinase-1
Grafts
Kidney Transplantation
Tissue Donors
Tissue
Recovery
Serum
Transplants
Kidney
Dialysis
Metalloproteases
Biopsy
Living Donors
Microarrays
Genes
Monitoring

All Science Journal Classification (ASJC) codes

  • Biomedical Engineering
  • Cell Biology
  • Transplantation

Cite this

Kusaka, Mamoru ; Kuroyanagi, Yoko ; Ichino, Manabu ; Sasaki, Hitomi ; Maruyama, Takahiro ; Hayakawa, Kunihiro ; Shiroki, Ryoichi ; Sugitani, Atsushi ; Kurahashi, Hiroki ; Hoshinaga, Kiyotaka. / Serum tissue inhibitor of metalloproteinases 1 (TIMP-1) predicts organ recovery from delayed graft function after kidney transplantation from donors after cardiac death. In: Cell Transplantation. 2010 ; Vol. 19, No. 6-7. pp. 723-729.
@article{4e45b2a7b14d4a9aa9daaf1373366a27,
title = "Serum tissue inhibitor of metalloproteinases 1 (TIMP-1) predicts organ recovery from delayed graft function after kidney transplantation from donors after cardiac death",
abstract = "Donors after cardiac death (DCD) have recently become an important source of renal transplants to alleviate the shortage of renal grafts in kidney transplantation (KTx), although DCD kidneys often have complications associated with a delayed graft function (DGF). A microarray-based approach using renal biopsy samples obtained at 1 h after KTx from DCD identified the tissue inhibitor of metalloproteinases 1 (TIMP-1) gene as a potential predictive marker for DGF. The current study measured serum TIMP-1 in patients undergoing KTx and analyzed the time course after KTx. The average serum TIMP-1 level before KTx was 240 ± 10 ng/ml (n = 34). In patients undergoing KTx from a living donor (n = 23), the serum TIMP-1 levels showed no increase after KTx (POD1: 226 ± 12, POD2: 211 ± 12, and POD3: 195 ± 10 ng/ml), but in one case, the only patient who required post-KTx HD due to DGF, the level on POD1 was the highest among subjects (361 ng/ml). In contrast, patients undergoing KTx from DCDs (n = 11), the serum TIMP-1 levels increased rapidly after a KTx (POD1: 418 ± 32, POD2: 385 ± 42, and POD3: 278 ± 25 ng/ml). However, two patients who avoided post-KTx HD due to the immediate function of the graft did not show increased levels (<370 ng/ml) on either POD1 or POD2. The peak serum TIMP-1 values appeared to correlate to the post-KTx dialysis period. Furthermore, the increment of serum TIMP-1 on the early POD was found to be predictive of immediate or delayed function of the grafts. These data suggest that monitoring of serum TIMP-1 levels allow the prediction of graft recovery and the need for HD after a KTx from a DCD.",
author = "Mamoru Kusaka and Yoko Kuroyanagi and Manabu Ichino and Hitomi Sasaki and Takahiro Maruyama and Kunihiro Hayakawa and Ryoichi Shiroki and Atsushi Sugitani and Hiroki Kurahashi and Kiyotaka Hoshinaga",
year = "2010",
month = "11",
day = "1",
doi = "10.3727/096368910X508825",
language = "English",
volume = "19",
pages = "723--729",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "6-7",

}

Serum tissue inhibitor of metalloproteinases 1 (TIMP-1) predicts organ recovery from delayed graft function after kidney transplantation from donors after cardiac death. / Kusaka, Mamoru; Kuroyanagi, Yoko; Ichino, Manabu; Sasaki, Hitomi; Maruyama, Takahiro; Hayakawa, Kunihiro; Shiroki, Ryoichi; Sugitani, Atsushi; Kurahashi, Hiroki; Hoshinaga, Kiyotaka.

In: Cell Transplantation, Vol. 19, No. 6-7, 01.11.2010, p. 723-729.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Serum tissue inhibitor of metalloproteinases 1 (TIMP-1) predicts organ recovery from delayed graft function after kidney transplantation from donors after cardiac death

AU - Kusaka, Mamoru

AU - Kuroyanagi, Yoko

AU - Ichino, Manabu

AU - Sasaki, Hitomi

AU - Maruyama, Takahiro

AU - Hayakawa, Kunihiro

AU - Shiroki, Ryoichi

AU - Sugitani, Atsushi

AU - Kurahashi, Hiroki

AU - Hoshinaga, Kiyotaka

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Donors after cardiac death (DCD) have recently become an important source of renal transplants to alleviate the shortage of renal grafts in kidney transplantation (KTx), although DCD kidneys often have complications associated with a delayed graft function (DGF). A microarray-based approach using renal biopsy samples obtained at 1 h after KTx from DCD identified the tissue inhibitor of metalloproteinases 1 (TIMP-1) gene as a potential predictive marker for DGF. The current study measured serum TIMP-1 in patients undergoing KTx and analyzed the time course after KTx. The average serum TIMP-1 level before KTx was 240 ± 10 ng/ml (n = 34). In patients undergoing KTx from a living donor (n = 23), the serum TIMP-1 levels showed no increase after KTx (POD1: 226 ± 12, POD2: 211 ± 12, and POD3: 195 ± 10 ng/ml), but in one case, the only patient who required post-KTx HD due to DGF, the level on POD1 was the highest among subjects (361 ng/ml). In contrast, patients undergoing KTx from DCDs (n = 11), the serum TIMP-1 levels increased rapidly after a KTx (POD1: 418 ± 32, POD2: 385 ± 42, and POD3: 278 ± 25 ng/ml). However, two patients who avoided post-KTx HD due to the immediate function of the graft did not show increased levels (<370 ng/ml) on either POD1 or POD2. The peak serum TIMP-1 values appeared to correlate to the post-KTx dialysis period. Furthermore, the increment of serum TIMP-1 on the early POD was found to be predictive of immediate or delayed function of the grafts. These data suggest that monitoring of serum TIMP-1 levels allow the prediction of graft recovery and the need for HD after a KTx from a DCD.

AB - Donors after cardiac death (DCD) have recently become an important source of renal transplants to alleviate the shortage of renal grafts in kidney transplantation (KTx), although DCD kidneys often have complications associated with a delayed graft function (DGF). A microarray-based approach using renal biopsy samples obtained at 1 h after KTx from DCD identified the tissue inhibitor of metalloproteinases 1 (TIMP-1) gene as a potential predictive marker for DGF. The current study measured serum TIMP-1 in patients undergoing KTx and analyzed the time course after KTx. The average serum TIMP-1 level before KTx was 240 ± 10 ng/ml (n = 34). In patients undergoing KTx from a living donor (n = 23), the serum TIMP-1 levels showed no increase after KTx (POD1: 226 ± 12, POD2: 211 ± 12, and POD3: 195 ± 10 ng/ml), but in one case, the only patient who required post-KTx HD due to DGF, the level on POD1 was the highest among subjects (361 ng/ml). In contrast, patients undergoing KTx from DCDs (n = 11), the serum TIMP-1 levels increased rapidly after a KTx (POD1: 418 ± 32, POD2: 385 ± 42, and POD3: 278 ± 25 ng/ml). However, two patients who avoided post-KTx HD due to the immediate function of the graft did not show increased levels (<370 ng/ml) on either POD1 or POD2. The peak serum TIMP-1 values appeared to correlate to the post-KTx dialysis period. Furthermore, the increment of serum TIMP-1 on the early POD was found to be predictive of immediate or delayed function of the grafts. These data suggest that monitoring of serum TIMP-1 levels allow the prediction of graft recovery and the need for HD after a KTx from a DCD.

UR - http://www.scopus.com/inward/record.url?scp=77958593605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958593605&partnerID=8YFLogxK

U2 - 10.3727/096368910X508825

DO - 10.3727/096368910X508825

M3 - Article

C2 - 20525436

AN - SCOPUS:77958593605

VL - 19

SP - 723

EP - 729

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 6-7

ER -